Home › Posts tagged Multiple Sklerose
Blog Archives

Schwere Nebenwirkungen: Das MS-Arzneimittel Daclizumab (Zinbryta) weltweit vom Markt genommen

Posted on by by Posted in Behördliche Mitteilung, Gravierende Unerwünschte Nebenwirkung, Marktrückzug, Thasso Post, Theragenomische Medizin No Comments ↓

02. März 2018 – Daclizumab (Zinbryta) wurde im Mai 2016 in den USA, im Juli 2016 in der Europäischen Union (EU) und im Januar 2017 auch in der Schweiz zur Behandlung der schubförmig auftretenden Multiplen Sklerose auf dem Markt zugelassen. Daclizumab (Zinbryta) ist ein therapeutischer humanisierter monoklonaler Antikörper gegen den Interleukin-2-Rezeptor (genauer: gegen die α-Kette CD25),

…

Read more ›

Tags: , , , , , , , , ,

Natalizumab (Tysabri)’s Risiko für PML

Posted on by by Posted in Behördliche Mitteilung, Gravierende Unerwünschte Nebenwirkung, Thasso Post, Theragenomische Medizin, Unerwünschte Arzneimittel Nebenwirkungen No Comments ↓

natali-ii

20. September 2016 – Swissmedic, das Schweizer Heilmittelinstitut, kommuniziert in der Form einer sog. Health Professional Communication (HPC) aktualisierte Massnahmen um dem Risiko von progressiv multifokaler Leukoencephalopathie (PML) unter Therapie mit Natalizumab (Tysabri) entgegenzuwirken.

…

Read more ›

Tags: , , , ,

BfArM: Strengere kardiovaskuläre Überwachung zu Beginn der Therapie mit Fingolimod [Gilenya] bei Patienten mit schubförmig-remittierend verlaufender Multipler Sklerose

Posted on by by Posted in Behördliche Mitteilung, Gravierende Unerwünschte Nebenwirkung, Thasso Post, Theragenomische Medizin No Comments ↓

27. Januar 2012 – Das BfArM hat heute mitgeteilt, dass ein “Rote Hand Brief” betreffend Fingolimod [Gilenya] mit untenstehendem Wortlaut von der Firma Novartis Pharma versandt wurde.

________________________

Novartis möchte Sie über wichtige zusätzliche Empfehlungen zu mit Fingolimod [Gilenya] informieren. Diese betreffen eine intensivere Überwachung der kardiovaskulären Funktionen innerhalb der ersten 6 Stunden nach Behandlungsbeginn mit Fingolimod [Gilenya],

…

Read more ›

Tags: , , , ,

thasso: spenden

thasso: zustände

thasso: neueste tweets

thasso: kürzliche kommentare

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

RSS random genetics

  • Single-cell RNA sequencing reveals details about individual cells in pancreatic tumors September 30, 2020
    Led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and by HonorHealth Research and Innovation Institute, an international team of researchers have described in detail the individual cells that comprise the pancreatic cancer microenvironment, a critical step in devising new treatment options for patients with this aggressive and difficult-to-treat disease.
  • Study: Neanderthal genes are a liability for COVID patients September 30, 2020
    Scientists say genes that some people have inherited from their Neanderthal ancestors may increase their likelihood of suffering severe forms of COVID-19.
  • Concealed cardiomyopathies revealed in cardiac arrest survivors September 30, 2020
    Centenary Institute researchers have discovered that genetic testing can identify "concealed cardiomyopathies" in nearly a quarter of sudden cardiac arrest (SCA) survivors who seem to have a normal heart.
  • Genetic risk of developing obesity is driven by variants that affect the brain September 29, 2020
    Some people are at higher risk of developing obesity because they possess genetic variants that affect how the brain processes sensory information and regulates feeding and behavior. The findings from scientists at the University of Copenhagen support a growing body of evidence that obesity is a disease whose roots are in the brain.
  • Inflammatory gene provides clue to obesity risk September 29, 2020
    A gene that helps to control inflammation increases the risk of obesity and could be turned off in mice to stop weight gain, a study from The University of Queensland has found.

RSS random science

  • Single-cell RNA sequencing reveals details about individual cells in pancreatic tumors September 30, 2020
    Led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and by HonorHealth Research and Innovation Institute, an international team of researchers have described in detail the individual cells that comprise the pancreatic cancer microenvironment, a critical step in devising new treatment options for patients with this aggressive and difficult-to-treat disease. […]
  • Ocean warming and acidification effects on calcareous phytoplankton communities September 30, 2020
    A new study led by researchers from the Institute of Environmental Science and Technology of the Universitat Autònoma de Barcelona (ICTA-UAB) warns that the negative effects of rapid ocean warming on planktonic communities will be exacerbated by ocean acidification.
  • Videos most effective in communicating with parents about secondhand smoke risks September 30, 2020
    The best way to communicate with parent smokers about the risks of secondhand smoke to their children is to use videos depicting the risks, as well as solutions to reduce those risks.
  • Antipsychotics for treating adult depression linked with higher mortality September 30, 2020
    Rutgers researchers, together with colleagues at Columbia University, have reported an increased mortality risk in adults with depression who initiated augmentation with newer antipsychotic medications compared to a control group that initiated augmentation with a second antidepressant.
  • Is it time to reframe the assisted dying debate? September 30, 2020
    Several articles published by The BMJ today explore the debate around assisted dying, in which, subject to safeguards, terminally ill people who are near to death, suffering, and of sound mind, could ask for drugs that they would take to end their lives.
Top